ATE194607T1 - Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung - Google Patents

Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung

Info

Publication number
ATE194607T1
ATE194607T1 AT96904993T AT96904993T ATE194607T1 AT E194607 T1 ATE194607 T1 AT E194607T1 AT 96904993 T AT96904993 T AT 96904993T AT 96904993 T AT96904993 T AT 96904993T AT E194607 T1 ATE194607 T1 AT E194607T1
Authority
AT
Austria
Prior art keywords
pct
sec
peak
piretanide
date
Prior art date
Application number
AT96904993T
Other languages
English (en)
Inventor
Yuji Chikaraishi
Yoshihisa Matsuda
Makoto Otsuka
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03321595A external-priority patent/JP3532987B2/ja
Priority claimed from JP03321695A external-priority patent/JP3532988B2/ja
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE194607T1 publication Critical patent/ATE194607T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96904993T 1995-02-22 1996-02-12 Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung ATE194607T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP03321595A JP3532987B2 (ja) 1995-02-22 1995-02-22 新規な無晶形ピレタニドおよびその製造方法
JP03321695A JP3532988B2 (ja) 1995-02-22 1995-02-22 ピレタニドの新規な結晶多形およびその製造方法
PCT/IB1996/000254 WO1996026197A1 (en) 1995-02-22 1996-02-12 Amorphous piretanide, piretanide polymorphs, process for their preparation and their use

Publications (1)

Publication Number Publication Date
ATE194607T1 true ATE194607T1 (de) 2000-07-15

Family

ID=26371876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904993T ATE194607T1 (de) 1995-02-22 1996-02-12 Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung

Country Status (14)

Country Link
US (1) US6096779A (de)
EP (1) EP0812320B1 (de)
KR (1) KR100419355B1 (de)
CN (1) CN1072215C (de)
AT (1) ATE194607T1 (de)
BR (1) BR9607295A (de)
CA (1) CA2213693C (de)
DE (1) DE69609314T2 (de)
DK (1) DK0812320T3 (de)
ES (1) ES2150105T3 (de)
GR (1) GR3034605T3 (de)
MX (1) MX9706339A (de)
PT (1) PT812320E (de)
WO (1) WO1996026197A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
AU2003271740B2 (en) * 2002-05-16 2010-05-13 Janssen R&D Ireland Pseudopolymorphic forms of a HIV protease inhibitor
EP1734931A2 (de) * 2004-03-24 2006-12-27 Actavis Group Formulierungen von ramipril
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2419970C3 (de) * 1974-04-25 1980-06-12 Hoechst Ag, 6000 Frankfurt 3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung
JPS5283547A (en) * 1976-01-01 1977-07-12 Hoechst Ag Tertiary cyclic amine
DE2655331A1 (de) * 1976-12-07 1978-06-08 Hoechst Ag Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung
ATE66157T1 (de) * 1986-04-29 1991-08-15 Hoechst Roussel Pharma Schichtenstruktur fuer die verabreichung von chemikalien mit kontrollierter abgaberate.
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
JPH05230044A (ja) * 1992-02-21 1993-09-07 Hoechst Japan Ltd ピレタニドの新規な結晶多形

Also Published As

Publication number Publication date
WO1996026197A1 (en) 1996-08-29
DK0812320T3 (da) 2003-04-14
EP0812320B1 (de) 2000-07-12
DE69609314T2 (de) 2001-06-13
KR100419355B1 (ko) 2004-06-04
MX9706339A (es) 1998-07-31
KR19980702374A (ko) 1998-07-15
CA2213693A1 (en) 1996-08-29
ES2150105T3 (es) 2000-11-16
DE69609314D1 (de) 2000-08-17
BR9607295A (pt) 1997-11-25
HK1006783A1 (en) 1999-03-19
GR3034605T3 (en) 2001-01-31
US6096779A (en) 2000-08-01
CA2213693C (en) 2008-04-15
EP0812320A1 (de) 1997-12-17
CN1072215C (zh) 2001-10-03
PT812320E (pt) 2000-12-29
CN1175948A (zh) 1998-03-11

Similar Documents

Publication Publication Date Title
BG104561A (en) Aryl fused azapolycyclic compounds
ATE182333T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
ATE194607T1 (de) Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung
HU9602413D0 (en) Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
ATE237585T1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
DE69510212D1 (de) Colchicin-derivate sowie ihre therapeutische verwendung
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
ATE85334T1 (de) Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung.
ATE181832T1 (de) Pyrido-pyrimidindione, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO975921L (no) Fremstilling av bicykloheksanderivater
ATE123492T1 (de) Benzocycloalkylaminopyridinamine und verwandte verbindungen, verfahren zu ihrer herstellung, zwischenverbindungen und ihre verwendung als arzneimittel.
HRP950437B1 (en) N-substituted azabicycloheptane derivatives, their production and use
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
DE69517371D1 (de) 4-p-fluorbenzoyl-1-piperidinyl-propoxy-chromen-4-on derivate, deren herstellung und deren verwendung zur behandlung von psychosen und schizophrenie
IL108290A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
ATE13669T1 (de) 4-aryloxy-3-phenylpiperidin-derivate, zwischenprodukte, verfahren zur herstellung solcher verbindungen und ihre verwendung als arzneimittel.
DE68906647D1 (de) Hydroxy-1,2,3,4-tetrahydroaminoacridine, verfahren fuer ihre herstellung und ihre verwendung als arzneimittel.
DE3879234D1 (de) Substituierte 3-phenyl-7h-thiazolo(3,2 -b) (1,2,4)triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte.
ATE186640T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen
ATE139227T1 (de) Acylsulfonamido-und sulfonamidopyridin-2- carbonsäureester sowie ihre pyridin-n-oxide, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
IL117083A0 (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds
DE69917440D1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
ATE360611T1 (de) 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1h- benz(f)indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3767504D1 (de) Tetrahydrobenz(c,d)indol-derivate, ihre salze, verfahren zur herstellung, verwendung als arzneimittel, ihre zusammensetzungen und zwischenprodukte.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0812320

Country of ref document: EP